Boston Trust Walden Corp Medpace Holdings, Inc. Transaction History

Boston Trust Walden Corp

  • $14.1 Billion
  • Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 129,655 shares of MEDP stock, worth $44.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
129,655
Previous 157,951 17.91%
Holding current value
$44.4 Million
Previous $65.1 Million 33.53%
% of portfolio
0.31%
Previous 0.49%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$320.58 - $457.29 $9.07 Million - $12.9 Million
-28,296 Reduced 17.91%
129,655 $43.2 Million
Q2 2024

Jul 19, 2024
SELL
$372.0 - $424.34 $40.6 Million - $46.3 Million
-109,064 Reduced 40.85%
157,951 $65.1 Million
Q1 2024

Apr 22, 2024
SELL
$284.87 - $413.31 $63 Million - $91.4 Million
-221,256 Reduced 45.31%
267,015 $108 Million
Q4 2023

Jan 24, 2024
SELL
$227.52 - $312.68 $11.8 Million - $16.2 Million
-51,684 Reduced 9.57%
488,271 $150 Million
Q3 2023

Oct 18, 2023
SELL
$233.98 - $281.67 $2.33 Million - $2.8 Million
-9,952 Reduced 1.81%
539,955 $131 Million
Q2 2023

Jul 24, 2023
SELL
$187.26 - $240.17 $2.38 Million - $3.06 Million
-12,728 Reduced 2.26%
549,907 $132 Million
Q1 2023

Apr 19, 2023
BUY
$174.31 - $239.52 $2.65 Million - $3.64 Million
15,193 Added 2.78%
562,635 $106 Million
Q4 2022

Jan 20, 2023
SELL
$153.06 - $226.57 $23.2 Million - $34.4 Million
-151,618 Reduced 21.69%
547,442 $0
Q3 2022

Oct 19, 2022
BUY
$145.13 - $182.49 $1.49 Million - $1.88 Million
10,282 Added 1.49%
699,060 $110 Million
Q2 2022

Jul 22, 2022
BUY
$130.2 - $168.03 $1.79 Million - $2.32 Million
13,784 Added 2.04%
688,778 $103 Million
Q1 2022

Apr 20, 2022
BUY
$138.87 - $214.31 $25.9 Million - $40 Million
186,518 Added 38.18%
674,994 $110 Million
Q4 2021

Jan 21, 2022
SELL
$182.74 - $227.9 $7.29 Million - $9.1 Million
-39,915 Reduced 7.55%
488,476 $106 Million
Q3 2021

Oct 25, 2021
BUY
$170.18 - $198.21 $368,269 - $428,926
2,164 Added 0.41%
528,391 $100 Million
Q2 2021

Jul 22, 2021
SELL
$158.62 - $194.3 $2.68 Million - $3.28 Million
-16,891 Reduced 3.11%
526,227 $92.9 Million
Q1 2021

Apr 21, 2021
BUY
$132.02 - $168.26 $4.42 Million - $5.63 Million
33,488 Added 6.57%
543,118 $89.1 Million
Q4 2020

Jan 15, 2021
BUY
$109.38 - $149.19 $11.1 Million - $15.1 Million
101,346 Added 24.82%
509,630 $70.9 Million
Q3 2020

Oct 14, 2020
BUY
$92.95 - $130.61 $1.37 Million - $1.93 Million
14,749 Added 3.75%
408,284 $45.6 Million
Q2 2020

Jul 23, 2020
BUY
$68.08 - $95.68 $24.7 Million - $34.7 Million
362,970 Added 1187.53%
393,535 $36.6 Million
Q1 2020

Apr 21, 2020
BUY
$61.71 - $101.95 $1.89 Million - $3.12 Million
30,565 New
30,565 $2.24 Million

Others Institutions Holding MEDP

# of Institutions
616
Shares Held
25.1M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email